Research: Metformin may be effective in treating breast cancer that lacks Nischarin p

[News]

Research conducted by Suresh Alahari, PhD, Professor of Biochemistry and Genetics at LSU Health New Orleans School of Medicine, has found that metformin, a commonly prescribed drug for Type 2 Diabetes, may be effective in treating cancers that lack a protein called Nischarin.

More... (https://www.news-medical.net/news/20190920/Research-Metformin-may-be-effective-in-treating-breast-cancer-that-lacks-Nischarin-protein.aspx)